The invention is directed at the formulation of Mucuna pruiens, N Acetyl L Cysteine and Magnesium Citrate. This formulation augments dopamine in the striatal area of the human brain and stabilizes membranes by restoring normal neurotransmitter levels and decreasing endogenous catecholamines. These effects are beneficial in the short and long term treatment of addictive disease and addiction to chemical substances and addictive behaviors.

 
Web www.patentalert.com

< USE OF NITROXYL (HNO) FOR THE TREATMENT OF CANCERS OVEREXPRESSING MAT-8

> CISSUS QUADRANGULARIS PLANT EXTRACTS FOR TREATING OSTEOPOROSIS AND THE EXTRACTION PROCESS THEREOF

> CELL ACTIVATOR, COLLAGEN PRODUCTION PROMOTER, SKIN WHITENING AGENT, ANTIOXIDANT AGENT, ANTIINFLAMMATORY AGENT, AROMATASE ACTIVITY PROMOTER, PROTEASE ACTIVITY PROMOTER, EXTERNAL PREPARATION FOR SKIN, AND FOOD

~ 00558